Rhodes Pharmaceuticals Recalls Aptensio XR Capsules Due to Dissolution Failure
Rhodes Pharmaceuticals is recalling Aptensio XR capsules because they failed to meet dissolution specifications. The affected lot was distributed nationwide.
- Product
- Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed by: Rhodes Pharmaceuticals L.P., Coventry, RI 02816. Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834. NDC 42858-402-45
- Category
- Drug
- Distribution
- Distributed nationwide